Serum Ferritin in Healthy Women and Breast Cancer Patients

Ćujić, Danica; Stefanoska, Ivana; Golubović, Snežana

doi:10.2478/v10011-010-0027-6

Cited by 13 publications

(5 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This well confirmed by a number of retrospective studies which have also demonstrated that the increase in serum ferritin level is associated with the higher risk of SGA in pregnancies with beta thalassemia intermedia (Gaspar, Ortega, & Moreiras, 1993;Origa et al, 2010;Uberos, 2000;Višnjevac, Segedi, Ćurčić, Višnjevac, & Stajić, 2011). Pregnancies complicated by IUGR have higher serum ferritin level due to decrease in ferritin and iron absorption by placenta (Bashiri, Burstein, Sheiner, & Mazor, 2003;Cogswell, Parvanta, Ickes, Yip, & Brittenham, 2003;Ćujić D, 2011;Haram, Svendsen, & Myking, 2007;Ronnenberg et al, 2004;Uberos, 2000).…”

Section: Discussionmentioning

confidence: 76%

The Effect of Hemoglobin Correction by Blood Transfusion on Pregnancy Outcomes in Minor and Intermedia Thalassemia Patients: A Single-Blind Controlled Randomized Clinical Trial

Najafian¹,

Ahmadzadeh²,

Barati³

et al. 2016

GJHS

View full text Add to dashboard Cite

To the best of our knowledge, there is no prospective trial study assessing the management of β-thalassemia by blood transfusion in pregnancy. The aim of this study was to investigate the effect of blood transfusion on maternal and neonatal outcomes in pregnant patients with beta thalassemia minor and intermedia. We did this randomized, single -blind, controlled clinical trial on 36 pregnant women with β thalassemia minor and intermedia at two tertiary hospitals of Imam Khomeini and Shafa in Ahvaz, Iran from January 2016 to July 2016. Patients were randomly assigned to receive either packed cell or not (control group) during pregnancy (ratio 1:1). The main outcomes of interest transfusion times, abortion, preterm delivery, type of delivery (cesarean or vaginal), stillbirth, birth weight, low birth weight, very low birth weight, small for gestational age, low Apgar score (≤7) at 1 and 5 minutes, oligohydramnios, fetal anomalies , and NICU admission. The median of blood transfusion in intervention group during pregnancy was two blood units. The cesarean section rate did not significantly differ between the intervention and control groups (72.2% and 44.4%, respectively, P=0.2). Two infants in intervention group experienced with LBW, one with SGA, one with low Apgar score, two with oligohydramnios, and one with NICU admission, while none in control group experienced these complications. The mean birth weight of infants in intervention group was significantly lower than control group (P value 0.002). The comparison between two groups showed that the adverse maternal and neonatal outcomes, especially low birth weight and preterm delivery were higher in intervention group.

show abstract

Section: Discussionmentioning

confidence: 76%

The Effect of Hemoglobin Correction by Blood Transfusion on Pregnancy Outcomes in Minor and Intermedia Thalassemia Patients: A Single-Blind Controlled Randomized Clinical Trial

Najafian¹,

Ahmadzadeh²,

Barati³

et al. 2016

GJHS

View full text Add to dashboard Cite

show abstract

“…Ćujić 등의 연구에서는 (7) 조기 유방암 환자와 진행된 유방암 환자의 두 군 모두 정상 폐경 전 여성보다 ferritin 값이 증가되어 있었고 정상 대조군 250명과 조기 유방암 환자 229명의 ferritin 수치를 비교한 Jacobs의 연 구에서도 유방암 환자군이 정상 대조군보다 유의하게 ferritin 수치가 높았다 (18). 115명의 폐암 환자와 74명의 양성 폐질환 환자를 대상으로 한 연구에서 양성 폐질환 환자보다 폐암 환자의 혈청 ferritin 수치가 유의하게 높 았고 (11), Ito 등에 의해 진행된 ferritin과 자궁경부암과의 연구도 (13) Table 4).…”

Section: 서 론unclassified

Prognostic Value of Serum Ferritin in Terminally Ill Cancer Patients

Lee

Choi

Hwang

et al. 2015

Korean J Hosp Palliat Care

View full text Add to dashboard Cite

“…Thus, breast cancer may exist for a long period as either a non invasive disease or an invasive but non metastatic disease. [4][5][6] These facts have significant clinical ramifications. 7 Rising numbers of cases of breast cancer in India are the more young ladies affected.…”

Section: Introductionmentioning

confidence: 99%

Serum ferritin, lactate dehydrogenase, and gamma glutamyl transferase levels in patients with breast carcinoma

S¹,

Deepak²,

Mahmood³

2021

IJCBR

View full text Add to dashboard Cite

Cancer also known as malignant neoplasm, is a broad group of various diseases. In cancer, cells divide and grow uncontrollably, forming malignant tumours, and invade nearby parts of the body. There are over 200 different known cancers that afflict humans. Malignant neoplastic lesions are the eighth leading cause accounting for 6.7% of the total medically certified deaths in India. Breast cancer is by far the most frequent cancer among women with an estimated 2.58 million new cancer cases diagnosed in 2019 (23% of all cancers), and ranks second overall (10.9% of all cancers). It is now the most common cancer both in developed and developing regions with around 690000 new cases estimated in each region (population ratio1:4). Breast cancer is the Most Common cancer in all urban areas in India, and 2nd most common in the rural areas. The most recent data Population Based Cancer Registry PBCR 2016 -2018 tells us that breast cancer accounts for 25% to 31% of all cancers in women in cities (Mumbai, Delhi, Chennai, Ahmedabad, Bengaluru, Bhopal etc.). Breast cancer alone accounts for around 14% of total female neoplasm deaths.

show abstract

Serum Ferritin in Healthy Women and Breast Cancer Patients

Cited by 13 publications

References 19 publications

The Effect of Hemoglobin Correction by Blood Transfusion on Pregnancy Outcomes in Minor and Intermedia Thalassemia Patients: A Single-Blind Controlled Randomized Clinical Trial

The Effect of Hemoglobin Correction by Blood Transfusion on Pregnancy Outcomes in Minor and Intermedia Thalassemia Patients: A Single-Blind Controlled Randomized Clinical Trial

Prognostic Value of Serum Ferritin in Terminally Ill Cancer Patients

Serum ferritin, lactate dehydrogenase, and gamma glutamyl transferase levels in patients with breast carcinoma

Contact Info

Product

Resources

About